Cost-effectiveness of child-focused and parent-focused interventions in a child anxiety prevention program

Journal of Anxiety Disorders

Volumn 26, Issue 2, 2012, Pages 287-296

  Simon, Ellin ^a   Dirksen, Carmen ^b   Bögels, Susan ^c   Bodden, Denise ^d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Anxiety; Cost effectiveness; Economic evaluation; Intervention; Prevention

Indexed keywords

ANXIETY DISORDER; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; COPING BEHAVIOR; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HEALTH PROMOTION; HUMAN; INTERVENTION STUDY; MALE; OUTCOME ASSESSMENT; PARENTING EDUCATION; PATIENT ASSESSMENT; PREVENTIVE MEDICINE; PRIMARY SCHOOL; PSYCHOEDUCATION; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCREENING TEST;

ADULT; ANXIETY; ANXIETY DISORDERS; CHILD; CHOLESTYRAMINE RESIN; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PARENTS; PROGRAM EVALUATION;

EID: 84856270733     PISSN: 08876185     EISSN: 18737897     Source Type: Journal    
DOI: 10.1016/j.janxdis.2011.12.008     Document Type: Article

References (40)

1. Bodden D.H.M., Bögels S.M., Muris P. The diagnostic utility of the Screen for Child Anxiety Related Emotional Disorders-71 (SCARED-71). Behaviour Research and Therapy 2009, 47(5):418-425.
2. Bodden D.H.M., Bögels S.M., Nauta M., De Haan E., Ringrose J., Appelboom C., et al. Child versus family cognitive-behavioral therapy in clinically anxious youth: an efficacy and partial effectiveness study. Journal of the American Academy of Child and Adolescent Psychiatry 2008, 47(12):1384-1394.
3. Bodden D.H.M., Dirksen C.D., Bögels S.M. Societal burden of clinically anxious youth referred for treatment: a cost-of-illness study. Journal of Abnormal Child Psychology 2008, 36(4):487-497.
4. Bodden D.H.M., Dirksen C.D., Bögels S.M. Societal burden of clinically anxious youth referred for treatment: a cost-of-illness study. Journal of Abnormal Child Psychology 2008, 36:487-497.
5. Bodden D.H.M., Dirksen C.D., Bögels S.M., Nauta M.H., De Haan E., Ringrose J., et al. Cost- and cost-effectiveness of family CBT versus individual CBT in clinically anxious children. Clinical Child Psychology and Psychiatry 2008, 13:543-564.
6. Bögels S.M. Denken+Doen=Durven 2008, Bohn Stafleu van Loghum, Houten.
7. Bögels S.M., Phares V. Fathers' role in the etiology, prevention and treatment of child anxiety: a review and new model. Clinical Psychology Review 2008, 28:539-558.
8. Bögels S.M., Siqueland L. Family cognitive behavioral therapy for children and adolescents with clinical anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry 2006, 45:134-141.
9. Bögels S.M., Van Melick M. The relationship between child-report, parent self-report, and partner report of perceived parental rearing behaviors and attitudes in children and parents. Personality and Individual Differences 2004, 37:1583-1596.
10. Cobham V.E., Dadds M.R., Spence S.H. The role of parental anxiety in the treatment of childhood anxiety. Journal of Consulting and Clinical Psychology 1998, 66:893-905.
11. Costello E.J., Egger H., Angold A. The developmental epidemiology of anxiety disorders: phenomenology, prevalence, and comorbidity. Child and Adolescent Psychiatric Clinics of North America 2005, 14:631-648.
12. Dadds M.R., Roth J.H. Prevention of anxiety disorders: results of a universal trial with young children. Journal of Child and Family Studies 2008, 17:320-335.
13. Dadds M.R., Spence S.H., Holland D.E., Barrett P.M., Laurens K.R. Prevention and early intervention for anxiety disorders. Journal of Consulting and Clinical Psychology 1997, 65:627-635.
14. Drummond M.F., O'Brien B.J., Stoddart G.L., Torrance G.W. Methods for the economic evaluation of health care programmes 1997, Oxford Medical, Oxford, UK.
15. Essau C.A., Conradt J., Petermann F. Frequency, comorbidity, and psychosocial impairment of anxiety disorders in adolescents. Journal of Anxiety Disorders 2000, 14:263-279.
16. Fenwick E., Claxton K., Sculpher M.J. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Economics 2001, 10:779-787.
17. Freer C.B. Health diaries: a method of collecting health information. Journal of the Royal College of General Practitioners 1980, 30:279-282.
18. Goossens M.E.J.B., Rutten-Van Mölken M.P.M.H., Vlaeyen J.W.S., Van der Linden S.M.J.P. The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. Journal of Clinical Epidemiology 2000, 53:688-695.
19. Greenberg M.T., Domitrovich C., Bumbarger B. The prevention of mental disorders in school-aged children: current state of the field. Prevention & Treatment 2001, 4:1-62.
20. Guest J.F., Russ J., Lenox-Smith A. Cost-effectiveness of venlafaxine XL compared with diazepam in the treatment of generalised anxiety disorder in the United Kingdom. European Journal of Health Economics 2005, 6(2):136-145.
21. Heuzenroeder L., Donnelly M., Haby M.M., Mihalopoulos C., Rossell R., Carter R., et al. Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder. Australian and New Zealand Journal of Psychiatry 2004, 38:602-612.
22. Hirschfeld-Becker D.R.B.J., Faraone S.V., Robin J.A., Friedman D., Rosenthal J.M., Rosenbaum J.F. Pregnancy complications associated with childhood anxiety disorders. Depression and Anxiety 2004, 19:152-162.
23. Jörgensen T.R., Stein D.J., DeSpiegel N., Drost P.B., Hemels M.E., Baldwin D.S. Cost-effectiveness analysis of escitalopram compared with paroxetine in treatment of generalized anxiety disorder in the United Kingdom. The Annals of Pharmacotherapy 2006, 40:1752-1758.
24. Katon W., Russo J., Sherbourne C., Stein M.B., Craske M., Fan M.Y., et al. Incremental cost-effectiveness of a collaborative care intervention for panic disorder. Psychological Medicine 2006, 36:353-363.
25. Kendall P.C., Safford S., Flannery-Schroeder E., Webb A. Child anxiety treatment: outcomes in adolescence and impact on substance use and depression at 7.4-year follow-up. Journal of Consulting and Clinical Psychology Review 2004, 72:276-287.
26. Knapp Economic evaluations and interventions for children and adolescents with mental health problems. Journal of Child Psychology and Psychiatry 1997, 38:3-25.
27. Kolbasovsky A., Reich L., Futterman R., Meyerkopf N. Reducing the number of emergency department visits and costs associated with anxiety: a randomized controlled study. American Journal of Managed Care 2007, 13:95-102.
28. Langley A.K., Bergman L., McCracken J., Piacentini J.C. Impairment in childhood anxiety disorders: preliminary examination of the Child Anxiety Impact Scale-Parent version. Journal of Child and Adolescent Psychopharmacology 2004, 14(1):105-114.
29. Oostenbrink J.B., Al M.J. The analysis of incomplete cost data due to dropout. Health Economics 2005, 14:763-776.
30. Oostenbrink J.B., Koopmanschap M.A., Rutten F.F.H. Handleiding voor kostenonderzoek: methoden en richtlijnprijzen voor economische evaluaties in de gezondheidszorg 2004, College voor zorgverzekeringen, Amstelveen.
31. Poos M.J.J.C., Smit J.M., Groen J., Kommer G.J., Slobbe L.J.C. Kosten van ziekten in Nederland 2005 2008, RIVM.
32. Rapee R.M. The development and modification of temperamental risk factor for anxiety disorders: prevention of a lifetime of anxiety?. Biological Psychiatry 2002, 52:947-957.
33. Rapee R.M., Kennedy S., Ingram M., Edwards S., Sweeney L. Prevention and early intervention of anxiety disorders in inhibited preschool children. Journal of Consulting and Clinical Psychology 2005, 73(3):488-497.
34. Roberge P., Marchand A., Reinharz D., Savard P. Cognitive-behavioral treatment for panic disorder with agoraphobia: a randomized, controlled trial and cost-effectiveness analysis. Behavior Modification 2008, 32:333-351.
35. Siebelink B.M., Treffers P.D.A. Nederlandse bewerking van het Anxiety Disorder Interview Schedule for DSM-IV: child version van W.K. Silverman en A.M Albana 2001, Swets & Zeitlinger, Lisse/Amsterdam.
36. Silverman W.K., Albano A.M. Anxiety disorders interview schedule for DSM-IV child version, child interview schedule 1996, The Psychological Corporation, San Antonio.
37. Silverman W.K., Saavedra L.M., Pina A.A. Test-retest reliability of anxiety symptoms and diagnoses with anxiety disorders interview schedule for DSM-IV child and parent version. Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40:937-944.
38. Simon E., Bögels S.M. Screening for anxiety disorders in children. European Journal of Child and Adolescent Psychiatry 2009, 18(10):625-634.
39. Simon E., Bögels S.M., Voncken M.J. Efficacy of child-focused and parent-focused interventions in a child anxiety prevention study. Journal of Clinical Child and Adolescent Psychology 2011, 40:204-219.
40. van Asselt A.D.I., van Mastrigt G.A.P.G., Dirksen C.D., Arntz A., Severens J.L., Kessels A.G.H. How to deal with cost differences at baseline. Pharmaeconomics 2009, 27(6):519-528.